نتائج البحث

Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta-analysis.

• Authors : Deng JH; Pharmacy Department, Longyan Second Hospital, Longyan, China.; Lai PH

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/adverse effects ; Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use ; Allopurinol*/Allopurinol*/Allopurinol*/adverse effects

• Source: Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13757.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination with Allopurinol in Patients with Tophaceous Gout

• Source: A Phase 2, Randomized, Open-Label, Allopurinol-Controlled, Multicenter Study with Two Optional Extensions to Evaluate the Safety and Efficacy of AR882 Alone or in

تفاصيل العنوان

Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease.

• Authors : Nagaraju SP; Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.; Shenoy SV

Subjects: Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/complications ; Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/diagnosis ; Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/drug therapy

• Source: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia [Saudi J Kidney Dis Transpl] 2023 Jul 01; Vol. Publisher: Medknow Country of Publication: Saudi Arabia NLM ID: 9436968 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Discovery of coumaric acid derivatives hinted by coastal marine source to seek for uric acid lowering agents.

• Authors : Yang YS; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.; Research and Development Center, Nanjing Shibeitai Biotechnology Co., Ltd., Nanjing, China.

Subjects: Allopurinol*/Allopurinol*/Allopurinol*/pharmacology ; Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use ; Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/drug therapy

• Source: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2163241.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101150203 Publication Model: Print Cited Medium: Internet ISSN: 1475-6374

تفاصيل العنوان

Synergistic Impacts of Alpinia oxyphylla Seed Extract and Allopurinol against Experimental Hyperuricemia.

• Authors : Sung YY; KM Science Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.; Kim DS

Subjects: Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use ; Alpinia*/Alpinia*/Alpinia*/chemistry ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/therapeutic use

• Source: BioMed research international [Biomed Res Int] 2022 Jun 11; Vol. 2022, pp. 2824535. Date of Electronic Publication: 2022 Jun 11 (Print Publication: 2022).Publisher: Wiley Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6141

تفاصيل العنوان

Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Signal detection and preventability from Vietnam National pharmacovigilance database.

• Authors : Huong PT; Department of Biochemistry, Hanoi University of Pharmacy, Hanoi, Vietnam.; Ha TN

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/epidemiology ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/etiology ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/prevention & control

• Source: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Dec; Vol. 47 (12), pp. 2014-2019. Date of Electronic Publication: 2022 Jul 18.Publisher: Country of Publication: England NLM ID: 8704308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2710

تفاصيل العنوان

Effects of allopurinol on renal function in patients with diabetes: a systematic review and meta-analysis.

• Authors : Luo Q; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing, China.

Subjects: Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/chemically induced ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/drug therapy ; Gout*

• Source: Renal failure [Ren Fail] 2022 Dec; Vol. 44 (1), pp. 806-814.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print Cited Medium: Internet ISSN: 1525-6049

تفاصيل العنوان

Low-dose febuxostat exhibits a superior renal-protective effect and non-inferior safety profile compared to allopurinol in chronic kidney disease patients complicated with hyperuricemia: A double-centre, randomized, controlled study.

• Authors : Yang N; Department of Nephrology, Shangluo Central Hospital, Shangluo, China.; Cao B

Subjects: Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

• Source: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Dec; Vol. 47 (12), pp. 2214-2222. Date of Electronic Publication: 2022 Nov 20.Publisher: Country of Publication: England NLM ID: 8704308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2710

تفاصيل العنوان

Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.

• Authors : Sakuma M; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.; Toyoda S

Subjects: Allopurinol/Allopurinol/Allopurinol/*administration & dosage ; Heart Failure/Heart Failure/Heart Failure/*drug therapy ; Hyperuricemia/Hyperuricemia/Hyperuricemia/*drug therapy

• Source: PloS one [PLoS One] 2022 Jan 25; Vol. 17 (1), pp. e0261445. Date of Electronic Publication: 2022 Jan 25 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Treatment efficacy of febuxostat compared with allopurinol in hyperuricemia patients with hypertensive: A randomized, singleblind controlled trial.

• Authors : Son Kim Tran¹; Binh Thanh Huynh¹; Cuong Tan Vo²

• Source: Journal of Applied Pharmaceutical Science. Jun2024, Vol. 14 Issue 6, p90-96. 7p.

تفاصيل العنوان